Try
EyePoint, Inc.
EYPTUnited States
63 filed reports · 492 financial concepts · 0 earnings calls · 0 media appearances
Filed reports
63 reports · Mar 2010 to Jun 2026Each report counts once it has at least one extracted financial fact. Also extracted from these reports: 3 guidance figures.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Quarterly · 10-QSEC EDGAR | 44 | 5,608 | Dec 2011 to Jun 2026 |
| Annual · 10-KSEC EDGAR | 14 | 4,936 | Jun 2012 to Dec 2025 |
| Current · 8-KSEC EDGAR | 3 | 5 | Mar 2010 to Jun 2026 |
| Annual · 10-K/ASEC EDGAR | 1 | 1 | Dec 2020 |
| Quarterly · 10-Q/ASEC EDGAR | 1 | 65 | Sep 2011 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2026 Q2 | 10-Q | Jun 30, 2026 | Aug 5, 2026 | 305 | Open |
| FY2026 Q2 | 8-K | Jun 30, 2026 | Aug 5, 2026 | 2 | Open |
| FY2026 Q1 | 10-Q | Mar 31, 2026 | May 7, 2026 | 191 | Open |
| FY2025 | 10-K | Dec 31, 2025 | Mar 5, 2026 | 523 | Open |
| FY2025 Q3 | 10-Q | Sep 30, 2025 | Nov 6, 2025 | 204 | Open |
| FY2025 Q2 | 10-Q | Jun 30, 2025 | Aug 7, 2025 | 134 | Open |
| FY2025 Q1 | 10-Q | Mar 31, 2025 | May 8, 2025 | 138 | Open |
| FY2024 | 10-K | Dec 31, 2024 | Mar 6, 2025 | 352 | Open |
| FY2024 Q3 | 10-Q | Sep 30, 2024 | Nov 7, 2024 | 145 | Open |
| FY2024 Q2 | 10-Q | Jun 30, 2024 | Aug 8, 2024 | 138 | Open |
| FY2024 Q1 | 10-Q | Mar 31, 2024 | May 9, 2024 | 132 | Open |
| FY2023 | 10-K | Dec 31, 2023 | Mar 8, 2024 | 346 | Open |
Financial data
492 concepts · 10,615 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial475 concepts · 10,254 facts · Jun 2010 to Jul 2026
- Cash and cash equivalents at carrying value84 · Jun 2010 to Jun 2026
- General and administrative expense (US GAAP)81 · Jun 2010 to Jun 2026
- Net income loss81 · Jun 2010 to Jun 2026
- Operating expenses (US GAAP)81 · Jun 2010 to Jun 2026
- Operating income loss81 · Jun 2010 to Jun 2026
- Research and development expense81 · Jun 2010 to Jun 2026
- Revenue81 · Jun 2010 to Jun 2026
- Stockholders equity (US GAAP)81 · Jun 2010 to Jun 2026
- Common stock shares authorized80 · Jun 2011 to Jun 2026
- Payments to acquire property plant and equipment80 · Jun 2010 to Jun 2026
- Share based compensation80 · Jun 2010 to Jun 2026
- Accounts and other receivables net current79 · Jun 2011 to Jun 2026
- Accounts payable current79 · Jun 2011 to Jun 2026
- Accrued liabilities current79 · Jun 2011 to Jun 2026
- Accumulated other comprehensive income loss net of tax79 · Jun 2011 to Jun 2026
- Assets79 · Jun 2011 to Jun 2026
- Assets current79 · Jun 2011 to Jun 2026
- Common stock par or stated value per share79 · Jun 2011 to Jun 2026
- Common stock shares issued79 · Jun 2011 to Jun 2026
- Common stock shares outstanding79 · Jun 2011 to Jun 2026
- Common stock value79 · Jun 2011 to Jun 2026
- Liabilities79 · Jun 2011 to Jun 2026
- Liabilities and stockholders equity79 · Jun 2011 to Jun 2026
- Liabilities current79 · Jun 2011 to Jun 2026
Product5 concepts · 249 facts · Jun 2015 to Jun 2026
- Revenue212 · Jun 2016 to Jun 2026
- ILUVIEN18 · Jun 2015 to Sep 2019
- YUTIQ14 · Sep 2019 to Mar 2026
- Revenue from related parties3 · Dec 2019 to Dec 2021
- DEXYCU2 · Dec 2018 to Dec 2019
Geography10 concepts · 107 facts · Jun 2010 to Jun 2026
- Revenue47 · Jun 2010 to Dec 2025
- Watertown16 · Jun 2014 to Dec 2017
- Property, Plant & Equipment, Net12 · Jun 2011 to Jun 2016
- U.K.7 · Sep 2016 to Jun 2017
- Other restructuring costs6 · Sep 2016 to Jun 2017
- Liberty Corner5 · Sep 2017 to Dec 2017
- Restructuring charges5 · Jun 2016 to Jun 2017
- Allocated share based compensation expense3 · Sep 2016 to Mar 2017
- Increase decrease in operating lease liability3 · Mar 2024 to Jun 2026
- Massachusetts3 · Mar 2024 to Jun 2026
Guidance1 concepts · 3 facts · May 2010 to Jan 2023
- Revenue Guidance3 · May 2010 to Jan 2023
KPI1 concepts · 2 facts · Jun 2026
- Clinical Trial Participants2 · Jun 2026
Segments
356 factsFigures broken down by business line, region, product or another axis the company reports on.
Product or servicesrt:ProductOrServiceAxis7 members · 236 facts
- Royalty47 · Jun 2016 to Jun 2026
- YUTIQ Product46 · Mar 2019 to Mar 2026
- License And Collaboration Agreement44 · Jun 2017 to Jun 2026
- Product42 · Jun 2017 to Jun 2026
- Collaborative Research And Development29 · Jun 2016 to Mar 2023
- DEXYCU Product23 · Dec 2018 to Dec 2023
- ILUVIEN5 · Jun 2018 to Sep 2019
Statement geographicalus-gaap:StatementGeographicalAxis9 members · 70 facts
- GB24 · Jun 2011 to Jun 2017
- Malvern8 · Jun 2014 to Jun 2017
- Watertown8 · Jun 2016 to Dec 2017
- US7 · Jun 2011 to Jun 2017
- Gb6 · Jun 2011 to Jun 2016
- Us6 · Jun 2011 to Jun 2016
- Liberty Corner5 · Sep 2017 to Dec 2017
- United Kingdom3 · Jun 2010 to Jun 2012
- United States3 · Jun 2010 to Jun 2012
Statement geographicalsrt:StatementGeographicalAxis5 members · 37 facts
- GB14 · Jun 2016 to Dec 2025
- US10 · Jun 2016 to Dec 2025
- CN7 · Dec 2019 to Dec 2025
- Ma4 · Mar 2024 to Jun 2024
- Watertown Massachusetts2 · Jun 2026
Product or serviceus-gaap:ProductOrServiceAxis2 members · 13 facts
- Iluvien10 · Jun 2015 to Mar 2017
- ILUVIEN3 · Jun 2017 to Dec 2017
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
No commentary or risk-factor text for this company.
Earnings calls
Transcripts with management claims and analyst questions, one per fiscal period.
No earnings-call transcripts for this company.
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 17, 2026) and refreshed every few hours.